Maor S - Search Results

1

Insulin-like growth factor-I receptor (IGF-IR) translocates to nucleus and autoregulates IGF-IR gene expression in breast cancer cells.

Sarfstein R, Pasmanik-Chor M, Yeheskel A, Edry L, Shomron N, Warman N, Wertheimer E, Maor S, Shochat L, Werner H. Sarfstein R, et al. Among authors: maor s. J Biol Chem. 2012 Jan 20;287(4):2766-76. doi: 10.1074/jbc.M111.281782. Epub 2011 Nov 29. J Biol Chem. 2012. PMID: 22128190 Free PMC article.

2

The WT1 Wilms' tumor suppressor gene product interacts with estrogen receptor-alpha and regulates IGF-I receptor gene transcription in breast cancer cells.

Reizner N, Maor S, Sarfstein R, Abramovitch S, Welshons WV, Curran EM, Lee AV, Werner H. Reizner N, et al. Among authors: maor s. J Mol Endocrinol. 2005 Aug;35(1):135-44. doi: 10.1677/jme.1.01761. J Mol Endocrinol. 2005. PMID: 16087727

3

Transcriptional regulation of the insulin-like growth factor-I receptor gene in breast cancer.

Sarfstein R, Maor S, Reizner N, Abramovitch S, Werner H. Sarfstein R, et al. Among authors: maor s. Mol Cell Endocrinol. 2006 Jun 27;252(1-2):241-6. doi: 10.1016/j.mce.2006.03.018. Epub 2006 Apr 27. Mol Cell Endocrinol. 2006. PMID: 16647191 Review.

4

The insulin-like growth factor-I receptor gene: a downstream target for oncogene and tumor suppressor action.

Werner H, Maor S. Werner H, et al. Among authors: maor s. Trends Endocrinol Metab. 2006 Aug;17(6):236-42. doi: 10.1016/j.tem.2006.06.007. Epub 2006 Jul 11. Trends Endocrinol Metab. 2006. PMID: 16815029

5

Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1.

Maor S, Mayer D, Yarden RI, Lee AV, Sarfstein R, Werner H, Papa MZ. Maor S, et al. J Endocrinol. 2006 Dec;191(3):605-12. doi: 10.1677/joe.1.07016. J Endocrinol. 2006. PMID: 17170218

6

Insulin-like growth factor-I controls BRCA1 gene expression through activation of transcription factor Sp1.

Maor S, Papa MZ, Yarden RI, Friedman E, Lerenthal Y, Lee SW, Mayer D, Werner H. Maor S, et al. Horm Metab Res. 2007 Mar;39(3):179-85. doi: 10.1055/s-2007-970415. Horm Metab Res. 2007. PMID: 17373631

7

Elevated insulin-like growth factor-I receptor (IGF-IR) levels in primary breast tumors associated with BRCA1 mutations.

Maor S, Yosepovich A, Papa MZ, Yarden RI, Mayer D, Friedman E, Werner H. Maor S, et al. Cancer Lett. 2007 Nov 18;257(2):236-43. doi: 10.1016/j.canlet.2007.07.019. Epub 2007 Sep 4. Cancer Lett. 2007. PMID: 17766039

8

BRCA1 suppresses insulin-like growth factor-I receptor promoter activity: potential interaction between BRCA1 and Sp1.

Maor SB, Abramovitch S, Erdos MR, Brody LC, Werner H. Maor SB, et al. Mol Genet Metab. 2000 Feb;69(2):130-6. doi: 10.1006/mgme.1999.2958. Mol Genet Metab. 2000. PMID: 10720440

9

Caveolin-1 inhibits cell detachment-induced p53 activation and anoikis by upregulation of insulin-like growth factor-I receptors and signaling.

Ravid D, Maor S, Werner H, Liscovitch M. Ravid D, et al. Among authors: maor s. Oncogene. 2005 Feb 17;24(8):1338-47. doi: 10.1038/sj.onc.1208337. Oncogene. 2005. PMID: 15592498

10

Caveolin-1 inhibits anoikis and promotes survival signaling in cancer cells.

Ravid D, Maor S, Werner H, Liscovitch M. Ravid D, et al. Among authors: maor s. Adv Enzyme Regul. 2006;46:163-75. doi: 10.1016/j.advenzreg.2006.01.022. Epub 2006 Jul 20. Adv Enzyme Regul. 2006. PMID: 16857240 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters